NCT00001276Recruiting
Diagnosing and Treating Low Blood Sugar Levels
Fasting Hypoglycemia: Diagnosis and Treatment
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 3 Nov 1999
- Start date
- 21 May 1991
- Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NCT number
- NCT00001276
What you commit to
- Study type: Observational
- Planned participants: 1500
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with significant cardiac disease will be excluded.
Other
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Subjects who are pregnant per self-report.
- Medically unstable per the assessment of the PI.
Criteria the registry did not label
- INCLUSION CRITERIA:
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Male, females ages \>= 18.
- Patients with documented fasting blood glucose below 55 mg/dl.
- 4\. Patients with biochemical evidence for insulinoma or other pancreatic neuroendocrine tumors.
Age in the registry: 18 years to 120 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Institutes of Health Clinical Center Coordinator of this site? Confirm its status | Bethesda | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.